// App-Quantinova.ai

: Impact of endobronchial valves on patient reported outcomes in severe emphysema

Researchers

Presenter

  • Mark Dransfield

Principal Investigators

  • Surya Bhatt

  • Dirk-Jan Slebos

  • Karin Klooster

  • Frank Sciurba

  • Pallav Shah

  • Justin Garner

  • Sri Radhakrishnan

  • Narinder Shargill

  • Nathaniel Marchetti

  • Gerard Criner

Medical Centers

  • University of Alabama at Birmingham, Birmingham, Alabama, United States

  • University of Groningen, Groningen, Netherlands

  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States

  • Imperial College, London, United Kingdom

  • Pulmonx Corporation, Redwood City, United States of America

  • Drexel University, Philadelphia, United States of America

Locations

  • United States

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

  • Dyspnea

Biomarkers

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A